Syntel, Inc. (SYNT) Tops Q4 EPS by 14c, FY EPS Guidance Comes in Light

Syntel, Inc. (NASDAQ: SYNT) reported Q4 EPS of $0.88, $0.14 better than the analyst estimate of $0.74. Revenue for the quarter came in at $254.6 million versus the consensus estimate of $254.66 million.

GUIDANCE:

Syntel, Inc. sees FY2016 EPS of $2.75-$3.00, versus the consensus of $3.06. Syntel, Inc. sees FY2016 revenue of $1.025-1.065 billion, versus the consensus of $1.06 billion.

For earnings history and earnings-related data on Syntel, Inc. (SYNT) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c